Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Navigating Technology Transfer
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma
Trends in Single-Use Mixing Technologies and Insight into Pall and Lonza Ibex® Solutions
View All Featured ArticlesHeadline News
FDA expands TALZENNA plus XTANDI approval to earlier metastatic prostate cancer setting
Mo-Rez shows 62% response rate in platinum-resistant ovarian cancer
RYBREVANT FASPRO combination shows 77% response rate in first-line advanced head and neck cancer
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
In-line monitoring of surfactant clearance in viral vaccine downstream processing
Presented by Marina Kirkitadze, Head of Process Support & PAT Platform, Analytical Sciences at Sanofi Pasteur
15th February 2022
Continuous Bioprocessing Solutions Webinar Series Part II
Presented by Moderator: Kevin Marino, Presenter: Jon Petrone
23rd May 2017
Single Use Process for Production of AAV Gene Therapy Products
Presented by Lance Marquardt, Associate Director -Upstream Processing Gene Therapy, Hopewell Biologics Manufacturing at PTC Therapeutics, Vikas Gupta, Vice President and GM Downstream Bioprocessing and Gene Therapy, Rachel Legmann, Senior Director of Technology, Gene Therapy at Repligen and Gilbert Huang, Senior Field Application Scientist at Repligen
26th May 2022
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
